Valuation: Medpace Holdings, Inc.

Market Cap 17.08B 15.55B 14.33B 13.04B 24.46B 1,581B 25.71B 174B 69.33B 864B 64.08B 62.73B 2,711B P/E 2026 *
33.5x
P/E 2027 * 31.1x
Enterprise Value 16.27B 14.82B 13.65B 12.42B 23.3B 1,506B 24.48B 166B 66.04B 823B 61.03B 59.74B 2,582B EV / Sales 2026 *
5.71x
EV / Sales 2027 * 5.23x
Free-Float
81.13%
Yield 2026 *
-
Yield 2027 * -
1 day-3.70%
1 week-6.64%
Current month-6.36%
1 month-7.84%
3 months-1.64%
6 months+41.95%
Current year+8.70%
1 week 606.73
Extreme 606.73
659.99
1 month 606.73
Extreme 606.73
693.97
Current year 373
Extreme 373
693.97
1 year 373
Extreme 373
693.97
3 years 250.05
Extreme 250.05
693.97
5 years 126.94
Extreme 126.945
693.97
10 years 21.76
Extreme 21.76
693.97
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
29/10/26 Sell

Compliance Officer

-1,245 0.0045%
27/10/26 Sell

Chief Operating Officer

-3,940 0.0141%
21/10/26 Exercice

Chief Operating Officer

5,400 0.0193%
Change 5-day change 1-year change 3-year change Capi.($)
-3.70%-6.64%+3.16%+120.99% 17.08B
-2.49%-3.76%+53.38%+62.10% 63.66B
-0.63%-2.91%+6.55%+89.34% 58.56B
-2.37%-2.22%+21.77%+84.58% 54.19B
-2.19%-6.15%+12.43%+111.40% 44.66B
-1.89%-7.28%+9.30%+18.50% 40.51B
-0.93%-0.47%+19.34%+41.83% 36.27B
+1.11%-6.44%+127.46%+675.37% 34.87B
-0.80%+0.61%+76.27%+61.80% 32.26B
-2.17%+16.65%-28.89%+479.93% 31.01B
Average -1.61%-1.76%+30.08%+174.58% 41B
Weighted average by Cap. -1.57%-2.05%+30.64%+153.73%

Financials

2026 *2027 *
Net sales 2.85B 2.6B 2.39B 2.18B 4.08B 264B 4.29B 29.11B 11.57B 144B 10.69B 10.47B 452B 3.02B 2.75B 2.54B 2.31B 4.33B 280B 4.55B 30.86B 12.26B 153B 11.33B 11.1B 480B
Net income 521M 474M 437M 397M 746M 48.2B 784M 5.32B 2.11B 26.33B 1.95B 1.91B 82.63B 554M 504M 465M 423M 793M 51.28B 834M 5.66B 2.25B 28.01B 2.08B 2.03B 87.9B
Net Debt -812M -739M -681M -620M -1.16B -75.16B -1.22B -8.29B -3.3B -41.05B -3.05B -2.98B -129B -1.27B -1.16B -1.07B -971M -1.82B -118B -1.92B -13B -5.17B -64.35B -4.77B -4.67B -202B
Projected Income Statement - Annual - Medpace Holdings, Inc.
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,600
Date Price Change Volume
20/11/26 $610.54 -3.70% 236,773
19/11/26 $633.98 -1.99% 167,804
18/11/26 $646.87 -0.95% 211,746
17/11/26 $653.09 +0.75% 180,226
16/11/26 $648.20 -0.88% 230,405
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Medpace Holdings, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
610.54USD
Average target price
651.46USD
Spread / Average Target
+6.70%
  1. Stock Market
  2. Stocks
  3. MEDP Stock